Daniel J Taylor1, Allison K Wilkerson2, Kristi E Pruiksma3, Jacob M Williams3, Camilo J Ruggero1, Willie Hale3,4, Jim Mintz3,5, Katherine Marczyk Organek6, Karin L Nicholson7, Brett T Litz8,9,10, Stacey Young-McCaughan3, Katherine A Dondanville3, Elisa V Borah3,11, Antoinette Brundige3, Alan L Peterson3,4,12. 1. Department of Psychology, The University of North Texas, Denton, Texas. 2. Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina. 3. Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, Texas. 4. Department of Psychology, University of Texas at San Antonio, San Antonio, Texas. 5. Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, Texas. 6. Pulmonology, Cook Children's Hospital, Fort Worth, Texas. 7. Department of Medicine, Carl R. Darnall Army Medical Center, Fort Hood, Texas. 8. Massachusetts Veterans Epidemiological Research and Information Center, VA Boston Healthcare System, Boston, Massachusetts. 9. Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts. 10. Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts. 11. School of Social Work, University of Texas at Austin, Austin, Texas. 12. Research and Development Service, South Texas Veterans Health Care System, San Antonio, Texas.
Abstract
STUDY OBJECTIVES: To develop and demonstrate interrater reliability for a Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Sleep Disorders (SCISD). METHODS: The SCISD was designed to be a brief, reliable, and valid interview assessment of adult sleep disorders as defined by the DSM-5. A sample of 106 postdeployment active-duty military members seekingcognitive behavioral therapy for insomnia in a randomized clinical trial were assessed with the SCISD prior to treatment to determine eligibility. Audio recordings of these interviews were double-scored for interrater reliability. RESULTS: The interview is 8 pages long, includes 20 to 51 questions, and takes 10 to 20 minutes to administer. Of the nine major disorders included in the SCISD, six had prevalence rates high enough (ie, n ≥ 5) to include in analyses. Cohen kappa coefficient (κ) was used to assess interrater reliability for insomnia, hypersomnolence, obstructive sleep apnea hypopnea (OSAH), circadian rhythm sleep-wake, nightmare, and restless legs syndrome disorders. There was excellent interrater reliability for insomnia (1.0) and restless legs syndrome (0.83); very good reliability for nightmare disorder (0.78) and OSAH (0.73); and good reliability for hypersomnolence (0.50) and circadian rhythm sleep-wake disorders (0.50). CONCLUSIONS: The SCISD is a brief, structured clinical interview that is easy for clinicians to learn and use. The SCISD showed moderate to excellent interrater reliability for six of the major sleep disorders in the DSM-5 among active duty military seeking cognitive behavioral therapy for insomnia in a randomized clinical trial. Replication and extension studies are needed. CLINICAL TRIAL REGISTRATION: Registry: ClinicalTrials.gov; Title: Comparing Internet and In-Person Brief Cognitive Behavioral Therapy of Insomnia; Identifier: NCT01549899; URL: https://clinicaltrials.gov/ct2/show/NCT01549899.
RCT Entities:
STUDY OBJECTIVES: To develop and demonstrate interrater reliability for a Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Sleep Disorders (SCISD). METHODS: The SCISD was designed to be a brief, reliable, and valid interview assessment of adult sleep disorders as defined by the DSM-5. A sample of 106 postdeployment active-duty military members seeking cognitive behavioral therapy for insomnia in a randomized clinical trial were assessed with the SCISD prior to treatment to determine eligibility. Audio recordings of these interviews were double-scored for interrater reliability. RESULTS: The interview is 8 pages long, includes 20 to 51 questions, and takes 10 to 20 minutes to administer. Of the nine major disorders included in the SCISD, six had prevalence rates high enough (ie, n ≥ 5) to include in analyses. Cohen kappa coefficient (κ) was used to assess interrater reliability for insomnia, hypersomnolence, obstructive sleep apnea hypopnea (OSAH), circadian rhythm sleep-wake, nightmare, and restless legs syndrome disorders. There was excellent interrater reliability for insomnia (1.0) and restless legs syndrome (0.83); very good reliability for nightmare disorder (0.78) and OSAH (0.73); and good reliability for hypersomnolence (0.50) and circadian rhythm sleep-wake disorders (0.50). CONCLUSIONS: The SCISD is a brief, structured clinical interview that is easy for clinicians to learn and use. The SCISD showed moderate to excellent interrater reliability for six of the major sleep disorders in the DSM-5 among active duty military seeking cognitive behavioral therapy for insomnia in a randomized clinical trial. Replication and extension studies are needed. CLINICAL TRIAL REGISTRATION: Registry: ClinicalTrials.gov; Title: Comparing Internet and In-Person Brief Cognitive Behavioral Therapy of Insomnia; Identifier: NCT01549899; URL: https://clinicaltrials.gov/ct2/show/NCT01549899.
Authors: Daniel J Taylor; Alan L Peterson; Kristi E Pruiksma; Stacey Young-McCaughan; Karin Nicholson; Jim Mintz Journal: Sleep Date: 2017-06-01 Impact factor: 5.849
Authors: K R Merikangas; J Zhang; H Emsellem; S A Swanson; A Vgontzas; F Belouad; M M Blank; W Chen; M Einen; J P He; L Heaton; E Nakamura; S Rooholamini; E Mignot Journal: Sleep Med Date: 2014-02-15 Impact factor: 3.492
Authors: M Ramirez Basco; J Q Bostic; D Davies; A J Rush; B Witte; W Hendrickse; V Barnett Journal: Am J Psychiatry Date: 2000-10 Impact factor: 18.112
Authors: Daniel J Taylor; Kristi E Pruiksma; Willie J Hale; Kevin Kelly; Douglas Maurer; Alan L Peterson; Jim Mintz; Brett T Litz; Douglas E Williamson Journal: Sleep Date: 2016-10-01 Impact factor: 5.849
Authors: Kristi E Pruiksma; Danica C Slavish; Daniel J Taylor; Jessica R Dietch; Hannah Tyler; Megan Dolan; AnnaBelle O Bryan; Craig J Bryan Journal: Int J Behav Med Date: 2021-04
Authors: Shannon R Miles; Kristi E Pruiksma; Danica Slavish; Jessica R Dietch; Sophie Wardle-Pinkston; Brett T Litz; Matthew Rodgers; Karin L Nicholson; Stacey Young-McCaughan; Katherine A Dondanville; Risa Nakase-Richardson; Jim Mintz; Terence M Keane; Alan L Peterson; Patricia A Resick; Daniel J Taylor Journal: J Clin Sleep Med Date: 2022-06-01 Impact factor: 4.324
Authors: Kristi E Pruiksma; Daniel J Taylor; Jim Mintz; Karin L Nicholson; Matthew Rodgers; Stacey Young-McCaughan; Brittany N Hall-Clark; Brooke A Fina; Katherine A Dondanville; Briana Cobos; Sophie Wardle-Pinkston; Brett T Litz; John D Roache; Alan L Peterson Journal: J Clin Sleep Med Date: 2019-11-26 Impact factor: 4.062
Authors: Michael E Yurcheshen; Wilfred Pigeon; Carolina Z Marcus; Jonathan A Marcus; Susan Messing; Kevin Nguyen; Jennifer Marsella Journal: J Clin Sleep Med Date: 2021-07-01 Impact factor: 4.324
Authors: Allison K Wilkerson; Richard O Simmons; Gregory L Sahlem; Daniel J Taylor; Joshua P Smith; Sarah W Book; Aimee L McRae-Clark Journal: Am J Addict Date: 2021-06-23
Authors: Jessica K Salwen-Deremer; Michael T Smith; Hannah G Haskell; Colleen Schreyer; Corey A Siegel Journal: Dig Dis Sci Date: 2021-07-30 Impact factor: 3.487